What is Barrington Research’s Forecast for OPCH Q3 Earnings?

Option Care Health, Inc. (NASDAQ:OPCH) – Equities research analysts at Barrington Research lowered their Q3 2025 earnings estimates for shares of Option Care Health in a research report issued to clients and investors on Wednesday, April 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings of $0.37 per share for the quarter, down from their prior forecast of $0.39. Barrington Research has a “Outperform” rating and a $38.00 price target on the stock. The consensus estimate for Option Care Health’s current full-year earnings is $1.22 per share. Barrington Research also issued estimates for Option Care Health’s Q4 2025 earnings at $0.40 EPS.

OPCH has been the topic of several other reports. JPMorgan Chase & Co. increased their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a report on Thursday, March 6th. Jefferies Financial Group raised Option Care Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $38.00 to $40.00 in a research note on Wednesday, April 30th. JMP Securities reiterated a “market outperform” rating and issued a $36.00 price objective on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a report on Monday, January 13th. One investment analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Stock Down 0.2 %

OPCH opened at $32.74 on Monday. Option Care Health has a twelve month low of $21.39 and a twelve month high of $35.53. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The firm has a 50 day moving average price of $33.33 and a 200-day moving average price of $28.85. The stock has a market capitalization of $5.36 billion, a price-to-earnings ratio of 27.51, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The firm had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. During the same period in the prior year, the company posted $0.26 earnings per share. The company’s quarterly revenue was up 16.3% on a year-over-year basis.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company’s stock, valued at $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Murphy & Mullick Capital Management Corp purchased a new position in shares of Option Care Health in the fourth quarter valued at about $26,000. UMB Bank n.a. raised its stake in Option Care Health by 41.7% during the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after purchasing an additional 346 shares during the period. Signaturefd LLC raised its stake in Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock valued at $28,000 after purchasing an additional 1,005 shares during the period. Quadrant Capital Group LLC lifted its holdings in Option Care Health by 172.8% in the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after purchasing an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio boosted its stake in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock worth $43,000 after purchasing an additional 332 shares during the period. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.